High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma

Expert Review of Anticancer Therapy
Morie A GertzShaji K Kumar

Abstract

Multiple myeloma, for all practical purposes, remains an incurable malignancy; however, 5-year survival has improved substantially during the past 30 years. A major contribution to improved outcome is the use of high-dose chemotherapy and stem cell transplantation. This multifaceted approach to therapy requires an understanding of appropriate induction therapy, techniques for stem cell mobilization, appropriate conditioning and supportive care. Also of importance are prognosis, features that predict outcome, the suitability of transplant candidates, and post-transplantation maintenance therapy.

References

Jul 1, 1986·Annals of Internal Medicine·R AlexanianD Dixon
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K R DesikanG Tricot
Jul 22, 1999·Bone Marrow Transplantation·S V RajkumarM A Gertz
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D H VesoleB Barlogie
Jun 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G MartinelliM Cavo
Sep 23, 2000·Baillière's Best Practice & Research. Clinical Haematology·M Attal, J L Harousseau
Jul 10, 2001·British Journal of Haematology·F C SampsonE Vandenberghe
Sep 21, 2001·British Journal of Haematology·A BadrosG Tricot
Sep 28, 2002·Blood Reviews·Jean-Luc Harousseau, Michel Attal
Oct 3, 2002·British Journal of Haematology·Athanasios B-T FassasGuido Tricot
Nov 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S Vincent RajkumarThomas E Witzig
Jan 25, 2003·British Journal of Haematology·Juan José LahuertaUNKNOWN Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Osea
Feb 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D DamianiR Fanin

❮ Previous
Next ❯

Citations

Feb 3, 2007·Current Opinion in Oncology·Morie A GertzShaji Kumar
Jul 14, 2006·Mayo Clinic Proceedings·Morie A Gertz
Oct 13, 2007·Clinical Lymphoma & Myeloma·Sundar Jagannath
Apr 7, 2009·British Journal of Haematology·Sagar Lonial, Jamie Cavenagh
Dec 7, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William Bensinger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
R GreilESMO Guidelines Task Force
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Anas YounesMichael Wang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Thomas J SmithAntonio C Wolff
© 2021 Meta ULC. All rights reserved